Extrapulmonary manifestations of COVID-19
Recent clinical observations have prompted clinicians to think of COVID-19 as being more than a respiratory disease.
Recent clinical observations have prompted clinicians to think of COVID-19 as being more than a respiratory disease.
Ivy Riano: Tips to advise on how to plan your ASCO annual meeting / ASCO, ASCO Annual Meeting, cancer, Dartmouth-Hitchcock, early career oncologists, Ivy
Ivy Riano: Tips to advise on how to plan your ASCO annual meeting / ASCO, ASCO Annual Meeting, cancer, Dartmouth-Hitchcock, early career oncologists, Ivy
Don’t miss out on an engaging Tweetorial by Florez Lab and Young Lung Cancer Initiative / cancer, Florez Lab, Lung cancer, OncoDaily, Oncology, tweetorial,
Toni Choueiri: The February ASCO Plenary Series are here / ASCO, ASCO Plenary Series, cancer, DREAMM-7, FRUTIGA, gastric/GE junction adenocarcinoma,
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Immune checkpoint blockade (ICB) is a mainstay of treatment for advanced cancer, yet tumor response and host toxicity are heterogenous in those patients who receive…
Dr. Nazli Dizman has traveled across the world to pursue her passion for clinical and translational cancer research and further her career as a medical…
KCRS is the annual Kidney Cancer Research Summit presented by KidneyCAN. KCRS is a meeting focused on basic and translational science, as well as cutting…